65 results
Page 3 of 4
8-K
EX-99.1
h0k cb6s97199
24 Sep 20
JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study
10:45am
8-K
EX-99.1
kgot0 p5e
21 Sep 20
Regulation FD Disclosure
9:15am
8-K
EX-99.1
cqv5ogyru
16 Sep 20
JanOne Announces Strategic Plan to Divest its Legacy Businesses
4:29pm
8-K
EX-99.1
qbxjqk fu
3 Sep 20
Other Events
1:30pm
8-K
EX-99.1
e4wmbt
26 Aug 20
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript
6:01am
8-K
EX-99.1
rx6e0es bt2y
19 Aug 20
Regulation FD Disclosure
10:00am
8-K
EX-99.1
11h6jcm byxdyk28qldc
12 Aug 20
Regulation FD Disclosure
6:03am
8-K
EX-99.2
3y7u1m
12 Aug 20
Regulation FD Disclosure
6:03am
8-K
EX-99.1
xw4vac7 5z0b5qoa74tu
6 Aug 20
JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications
2:45pm
8-K
EX-99.1
91dsphos
30 Jul 20
JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain
9:42am
8-K
EX-99.1
db4q073c
30 Jun 20
One of the nation’s most renowned pain experts, Dr. Edgar Ross, joins JanOne’s Scientific Advisory Board
9:31am
8-K
EX-99.1
j5et2hzu5jpja2en706
25 Jun 20
Other Events
10:00am
8-K
EX-99.1
ypppp3bh9l15484kgip
7 Feb 20
JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer, for Phase 2b clinical formulation and development
12:00am
8-K
EX-99.1
3gju 26om
3 Dec 19
JanOne Names Tony Giordano, Ph.D., as Chief Scientific Officer
9:00am
8-K
EX-99.1
mmtetu
25 Nov 19
JanOne Acquires Worldwide, Exclusive License
8:00am